By Chuck Mikolajczak
NEW YORK (Reuters) - The U.S. dollar climbed on Monday after a flurry of economic data kept expectations intact for an interest rate hike from the Federal Reserve this year, while the euro stumbled on concerns over Greece's financial crisis and soft euro zone data.
The strengthening dollar held U.S. stocks in check and weighed on oil prices. Oil was also dented by expectations OPEC production would remain high.
Brent crude was off $1.11 at $64.45 a barrel, and U.S. crude lost 95 cents to $59.35 a barrel.
While U.S. economic data showed consumer spending remained flat in April, construction spending and manufacturing picked up steam, holding views steady that the Fed will begin to hike interest rates by the end of the year.
"We've hit this almost invisible wall in a stronger dollar, it is impacting everything," said Peter Kenny, chief market strategist at Clearpool Group in New York. "That is really the one-off that is really driving markets in terms of direction."
The U.S. data also sent yields on U.S. debt higher, as U.S. 10-year notes fell 17/32 in price to yield 2.1547 percent.
The Dow Jones industrial average rose 32.16 points, or 0.18 percent, to 18,042.84, the S&P 500 gained 2.63 points, or 0.12 percent, to 2,110.02 and the Nasdaq Composite added 2.93 points, or 0.06 percent, to 5,072.96.
The dollar index was up 0.76 percent at 97.648 after the greenback closed out May with a 2.4 percent climb, its tenth monthly gain in the last 11.
The euro , off 0.86 percent, lost ground after Greece failed to meet a self-imposed deadline on Sunday to reach a deal with lenders, keeping the possibility open of a debt default and possible exit from the euro zone. Officials close to creditors negotiating a funding-for-reform package with Greece denied a market rumour that a deal could be announced on Monday afternoon.
The euro was also weakened by surveys that showed manufacturing activity remained soft, boosting expectations for central banks to continue to take steps to support growth.
MSCI's all-country world index of the stock performance in 46 countries fell 0.11 percent. The pan-European FTSEurofirst 300 gained 0.12 percent to 1,588.27.34 points.
European stocks edged higher with Roche leading drug stocks higher following an encouraging company update and real estate shares getting some support from a positive sector note from JP Morgan.
(Reporting by Chuck Mikolajczak; Editing by Nick Zieminski)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
